It appears that ZnONPs combat the development of cardiac pathology associated with obesity directly through their antioxidant properties or indirectly via lowering oxidative stress, inflammatory markers, and iron overload or enhancement of cardiac SOD and GSH. Here, SOD1 is linked to obesity due to melanocortin 4 receptor deficiency.